Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study
Authors:
- VIPKIDS Study GroupVGVIPKIDS Study Group
- V. CherubiniVCV. Cherubini
- R. BonfantiRBR. Bonfanti
- I. RabboneIRI. Rabbone
- A. SalvatoniASA. Salvatoni
- 19 March 2013
- journal article
- Published by Springer Nature in Acta Diabetologica
- Vol. 51 (1) , 43-51
Abstract
A multi-centre, observational, cross-sectional study was carried out to determine whether the health-related quality of life (HRQOL) of adolescents with type 1 diabetes is affected by different insulin treatment systems, and which features of HRQOL are impacted by the respective insulin treatment. The study regarded 577 adolescents, aged 10–17 years, with type 1 diabetes treated with continuous subcutaneous insulin infusion (CSII) (n = 306) or multiple daily injections (MDI) (n = 271). The Insulin Delivery System Rating Questionnaire was validated in Italian and was self-completed by the subjects during a routine visit to the centres. Subjects were compared following the domains of the questionnaire. Good HRQOL was seen in subjects treated with either MDI or CSII. Significant differences were not found in the domains for general diabetes, including diabetes worries, social burden and psychological well-being. Multiple quantile regression analysis showed that CSII confers significant advantages in terms of HRQOL with improvements in treatment satisfaction, perceived clinical efficacy and reduction in treatment interference with daily activities. This favourable impact was more evident in subjects reporting lower HRQOL scores, suggesting that CSII may be especially useful for individuals perceiving a poor HRQOL. Analysis of the domains indicated that CSII was associated with a higher HRQOL than MDI. Life-course HRQOL evaluation using a standardised questionnaire can ensure better chronic disease management. This is particularly important when providing individualised care for adolescents, as they become increasingly responsible for managing their diabetes.Keywords
This publication has 16 references indexed in Scilit:
- Access of children and adolescents with type 1 diabetes to insulin pump therapy has greatly increased in France since 2001Diabetes & Metabolism, 2011
- Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trialsPediatric Diabetes, 2009
- Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusionDiabetic Medicine, 2008
- Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysisDiabetologia, 2008
- Cost-effectiveness of continuous subcutaneous insulin infusion (CSII) in children: illusion or delusion?Pediatric Diabetes, 2006
- Insulin Pump Therapy and Health-Related Quality of Life in Children and Adolescents with Type 1 DiabetesJournal of Pediatric Psychology, 2005
- Validity and Reliability of an Instrument for Assessing Health-Related Quality of Life and Treatment PreferencesDiabetes Care, 2005
- Continuous Subcutaneous Insulin Infusion at 25 YearsDiabetes Care, 2002
- Insulin pump therapy in Type 1 pediatric patients: now and into the year 2000Diabetes/Metabolism Research and Reviews, 1999
- Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications TrialThe Journal of Pediatrics, 1994